Magnesium Tartrate

Magnesium tartrate is a magnesium salt formed by binding elemental magnesium to tartaric acid, a naturally occurring organic acid found in grapes and wine. Upon ingestion, it theoretically dissociates into Mg²⁺ ions and tartrate, potentially delivering magnesium for enzymatic and physiological functions, though no clinical evidence currently confirms its efficacy or bioavailability.

Origin & History

Magnesium tartrate is a synthetic magnesium salt of tartaric acid with the molecular formula C₄H₄MgO₆ (anhydrous) or C₄H₁₄MgO₁₁ (2.5-hydrate form). It is chemically synthesized rather than extracted from natural sources, belonging to the metal carboxylate class of compounds. No natural biological sources or extraction methods are documented for this compound.

Historical & Cultural Context

No historical or traditional medicinal uses are documented in the chemical databases. Magnesium tartrate is presented solely as a synthetic compound without ties to traditional medicine systems or cultural practices.

Health Benefits

• No documented health benefits - no clinical trials or studies found in the research
• Theoretical magnesium supplementation potential - no evidence quality available
• May dissociate to provide Mg²⁺ ions - no specific studies support this
• No biomedical applications documented in available sources
• No therapeutic uses established through research

How It Works

Magnesium tartrate is hypothesized to dissociate in the gastrointestinal tract, releasing free Mg²⁺ ions that can act as cofactors for over 300 enzymatic reactions, including ATP synthesis via Mg-ATP complexes and activation of adenylate cyclase. The tartrate anion may influence intestinal absorption kinetics similarly to other organic acid chelates, potentially improving solubility compared to inorganic magnesium salts like magnesium oxide. However, no published pharmacokinetic studies have measured the actual dissociation rate, intestinal transport via TRPM6/TRPM7 channels, or tissue uptake of magnesium delivered specifically from the tartrate salt form.

Scientific Research

No human clinical trials, RCTs, or meta-analyses specifically on magnesium tartrate were identified in the available sources. PubChem and related databases list only general literature and patents without PubMed PMIDs or study details for clinical outcomes.

Clinical Summary

As of the available research, no published clinical trials, randomized controlled studies, or observational human studies have specifically investigated magnesium tartrate supplementation. No documented data exist on bioavailability comparisons to reference forms such as magnesium citrate or magnesium glycinate, which have established absorption studies. The absence of peer-reviewed evidence means that claims regarding efficacy for muscle function, sleep, cardiovascular health, or any other endpoint cannot be substantiated for this specific salt form. Researchers and consumers should consider better-studied magnesium forms when evidence-based outcomes are the primary concern.

Nutritional Profile

Magnesium tartrate (C4H4MgO6) provides elemental magnesium at approximately 14-16% by molecular weight, meaning a 500mg dose delivers roughly 70-80mg of elemental Mg²⁺. As a magnesium salt of tartaric acid, it contains both the mineral component and the organic tartrate anion. The tartrate component is a dicarboxylic acid derivative naturally occurring in grapes and wine. No significant macronutrient content (protein, fat, carbohydrate) is present at supplemental doses. Bioavailability data specific to magnesium tartrate is absent from published literature; however, organic acid magnesium salts (such as magnesium citrate and malate) generally demonstrate superior absorption (~40-50% bioavailability) compared to inorganic forms like magnesium oxide (~4%), suggesting the tartrate form may follow a similar organic-salt absorption pattern via passive diffusion and active transport in the small intestine. No vitamin content is present.

Preparation & Dosage

No clinically studied dosage ranges or forms have been established for magnesium tartrate, as no clinical studies were found. General magnesium supplementation guidelines do not specify this tartrate form. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Magnesium tartrate pairs logically with Vitamin D3 (cholecalciferol), since magnesium is a required cofactor for the enzymes that convert D3 into its active hormonal form (calcitriol), making both nutrients mutually dependent for efficacy — low magnesium directly impairs vitamin D metabolism. It also stacks well with Vitamin B6 (pyridoxine at 10-25mg), as magnesium and B6 are co-transported into cells and together support GABA synthesis and neurological calming pathways, a combination studied in the context of stress and magnesium retention. Additionally, pairing with malic acid or broader electrolyte complexes (potassium, calcium at a 2:1 Ca:Mg ratio) supports balanced ion channel function, neuromuscular signaling, and prevents competitive absorption interference that can occur when calcium significantly dominates magnesium intake.

Safety & Interactions

No specific safety profile or toxicology data have been published for magnesium tartrate as a distinct compound; general magnesium supplementation risks apply, including diarrhea, nausea, and abdominal cramping at doses exceeding 350 mg elemental magnesium per day from supplemental sources. Magnesium in general can interact with bisphosphonates, fluoroquinolone and tetracycline antibiotics, and certain diuretics, reducing drug absorption or altering serum magnesium levels. Individuals with chronic kidney disease should avoid unsupervised magnesium supplementation due to impaired renal excretion and risk of hypermagnesemia. Pregnancy and breastfeeding safety for magnesium tartrate specifically is undocumented; standard magnesium supplementation during pregnancy is generally considered safe under medical supervision at recommended dietary allowance levels.